Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Brevipalpus obovatus isolate:mite

ABSTRACT: Brevipalpus obovatus Genome sequencing

PROVIDER: PRJNA1257969 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR33694212_1.fastq.gz	Fastqsanger.gz
	SRR33694212_2.fastq.gz	Fastqsanger.gz
	SRR33693682_1.fastq.gz	Fastqsanger.gz
	SRR33693682_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 9

Similar Datasets

Brevipalpus yothersi isolate:EMBRAPA2013

Project description:Brevipalpus yothersi isolate:EMBRAPA2013 Genome sequencing and assembly

| PRJNA490612 | ENA

Oulenziella bakeri isolate:mite

Project description:Oulenziella bakeri Genome sequencing

| PRJNA1260082 | ENA

Carpoglyphus lactis isolate:mite

Project description:Carpoglyphus lactis Genome sequencing

| PRJNA1260190 | ENA

Cosmoglyphus oudemansi isolate:mite

Project description:Cosmoglyphus oudemansi Genome sequencing

| PRJNA1263485 | ENA

Proteomes of Wenzhouxiangella isolate grown on three substrates

Project description:A new haloalkaliphilic species of Wenzhouxiangella, strain AB-CW3 was isolated from a system of alkaline soda lakes in the Kulunda Steppe. Its complete, circular genome was assembled from combined nanopore and illumina sequencing and its proteome was determined for three different experimental conditions: growth on Staphylococcus cells, casein, or peptone. AB-CW3 is an aerobic bacterium feeding mainly on proteins and peptides.

2020-11-03 | PXD021036 | Pride

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Brevipalpus obovatus

Project description:Brevipalpus obovatus overview

| PRJNA1283348 | ENA

Project description:Arabidopsis/Brevipalpus mite/CiLV-C interaction

| PRJNA454529 | ENA

RNA Seq of P. aeruginosa clinical isolate collection

Project description:Purpose : The goal of this study was to use RNA Seq to explore the correlation of gene expression of a collection of clinical P. aeruginosa isolates to various phenotypes, such as antimicrobial resistance, biofilm formation or virulence Methods : mRNA profiles were generated for Pseudomonas aerugionsa clinical samples derived from various geographical locations by deep sequencing. The removal of ribosomal RNA was performed using the Ribo-Zero Bacteria Kit (Illumina) and cDNA libraries were generated with the ScriptSeq v2 Kit (Illumina) . The samples were sequenced in single end mode on an Illumina HiSeq 2500 device and mRNA reads were trimmed and mapped to the NC_008463.1 (PA14) reference genome from NCBI using Stampy pipeline with defaut settings.

2019-04-08 | GSE123544 | GEO

Project description:Five Cardinium endosymbiont genomes in Brevipalpus mites

| PRJNA437437 | ENA